WM Capital mandated to distribute quick COVID test in Italy

Lifestyle SPA

02/11/2020 15:55

MILAN, Nov 2 (Reuters) - Italian franchising group WM
Capital  WMC.MI  said on Monday it had received a mandate from
China's Xiamen Boson Biotech for the distribution in Italy of
the Rapid Sars-CoV-2 Antigen Test for a quick diagnosis of the
coronavirus.
    WM Capital added the accord signed with Xiamen Boson Biotech
was not an exclusive one and for the moment it does not expect
any significant economic impact from the deal on its balance
sheet. 
     

 (Reporting by Agnieszka Flak, editing by Gianluca Semeraro)
 ((agnieszka.flak@thomsonreuters.com; +39 02 6612 9450; Reuters
Messaging: agnieszka.flak.thomsonreuters.com@reuters.net))